These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 23118425

  • 21. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P.
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
    Corbera-Bellalta M, Planas-Rigol E, Lozano E, Terrades-García N, Alba MA, Prieto-González S, García-Martínez A, Albero R, Enjuanes A, Espígol-Frigolé G, Hernández-Rodríguez J, Roux-Lombard P, Ferlin WG, Dayer JM, Kosco-Vilbois MH, Cid MC.
    Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852
    [Abstract] [Full Text] [Related]

  • 24. β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy.
    Antonelli A, Ferrari SM, Frascerra S, Ruffilli I, Pupilli C, Bernini G, Sellari-Franceschini S, Gelmini S, Ferrannini E, Fallahi P.
    J Endocrinol; 2012 May; 213(2):183-91. PubMed ID: 22378921
    [Abstract] [Full Text] [Related]

  • 25. Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists.
    Antonelli A, Ferrari SM, Mancusi C, Mazzi V, Pupilli C, Centanni M, Ferri C, Ferrannini E, Fallahi P.
    Immunobiology; 2013 May; 218(5):690-5. PubMed ID: 22944249
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture.
    Sato K, Satoh T, Shizume K, Ozawa M, Han DC, Imamura H, Tsushima T, Demura H, Kanaji Y, Ito Y.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1735-43. PubMed ID: 2112152
    [Abstract] [Full Text] [Related]

  • 27. The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.
    Awwad O, Coperchini F, Pignatti P, Denegri M, Massara S, Croce L, Di Buduo CA, Abbonante V, Balduini A, Chiovato L, Rotondi M.
    J Endocrinol Invest; 2018 Nov; 41(11):1275-1282. PubMed ID: 29546654
    [Abstract] [Full Text] [Related]

  • 28. Chemokine expression during development of fibrosis versus resolution in a murine model of granulomatous experimental autoimmune thyroiditis.
    Chen K, Wei Y, Alter A, Sharp GC, Braley-Mullen H.
    J Leukoc Biol; 2005 Sep; 78(3):716-24. PubMed ID: 15961577
    [Abstract] [Full Text] [Related]

  • 29. 15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications.
    Si Q, Zhao ML, Morgan AC, Brosnan CF, Lee SC.
    J Immunol; 2004 Sep 01; 173(5):3504-13. PubMed ID: 15322215
    [Abstract] [Full Text] [Related]

  • 30. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
    Antonelli A, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, Di Domenicantonio A, Ferri C.
    J Rheumatol; 2012 May 01; 39(5):979-85. PubMed ID: 22422499
    [Abstract] [Full Text] [Related]

  • 31. Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis.
    Uddin J, Garcia HH, Gilman RH, Gonzalez AE, Friedland JS.
    J Immunol; 2005 Sep 01; 175(5):3273-81. PubMed ID: 16116219
    [Abstract] [Full Text] [Related]

  • 32. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
    Liubomirski Y, Lerrer S, Meshel T, Morein D, Rubinstein-Achiasaf L, Sprinzak D, Wiemann S, Körner C, Ehrlich M, Ben-Baruch A.
    Front Immunol; 2019 Sep 01; 10():804. PubMed ID: 31105691
    [Abstract] [Full Text] [Related]

  • 33. Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines.
    Hiroi M, Ohmori Y.
    Biochem J; 2003 Dec 01; 376(Pt 2):393-402. PubMed ID: 12946268
    [Abstract] [Full Text] [Related]

  • 34. Detection and localization of chemokine gene expression in autoimmune thyroid disease.
    Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman AP.
    Clin Endocrinol (Oxf); 2003 Aug 01; 59(2):207-13. PubMed ID: 12864798
    [Abstract] [Full Text] [Related]

  • 35. Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells.
    Fallahi P, Foddis R, Elia G, Ragusa F, Patrizio A, Frenzilli G, Benvenga S, Cristaudo A, Antonelli A, Ferrari SM.
    Mol Med Rep; 2018 May 01; 17(5):7415-7420. PubMed ID: 29568907
    [Abstract] [Full Text] [Related]

  • 36. Regulation of interleukin-6 release by human thyrocytes.
    Weetman AP, Bright-Thomas R, Freeman M.
    J Endocrinol; 1990 Nov 01; 127(2):357-61. PubMed ID: 2174456
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characteristics of Proinflammatory Cytokines and Chemokines in Airways of Asthmatics: Relationships with Disease Severity and Infiltration of Inflammatory Cells.
    Yang T, Li Y, Lyu Z, Huang K, Corrigan CJ, Ying S, Wang W, Wang C.
    Chin Med J (Engl); 2017 Sep 05; 130(17):2033-2040. PubMed ID: 28836545
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.